Tower Research Capital LLC (TRC) - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,149
-61.4%
8,249
-39.5%
0.00%
-50.0%
Q2 2023$67,761
+161235.7%
13,634
+61.7%
0.00%
+100.0%
Q1 2023$42
-59.6%
8,434
-48.7%
0.00%
-75.0%
Q4 2022$104
-100.0%
16,454
-39.7%
0.00%
-20.0%
Q3 2022$295,000
+40.5%
27,278
+48.0%
0.01%0.0%
Q2 2022$210,000
-13.6%
18,427
-30.9%
0.01%
+150.0%
Q1 2022$243,000
+10.0%
26,665
+80.1%
0.00%
-50.0%
Q4 2021$221,000
-30.1%
14,806
+20.3%
0.00%
-50.0%
Q3 2021$316,000
+95.1%
12,307
+97.5%
0.01%
+100.0%
Q2 2021$162,000
-11.0%
6,230
+20.6%
0.00%
+33.3%
Q1 2021$182,000
+36.8%
5,165
-2.0%
0.00%
-25.0%
Q4 2020$133,000
+2.3%
5,272
+53.3%
0.00%
+300.0%
Q3 2020$130,000
-76.6%
3,439
-73.5%
0.00%
-95.7%
Q2 2020$556,000
+55500.0%
12,983
+20185.9%
0.02%
Q1 2020$1,000
-99.1%
64
-98.5%
0.00%
-100.0%
Q4 2019$110,000
+41.0%
4,216
+46.5%
0.01%
+80.0%
Q3 2019$78,000
+3800.0%
2,878
+3789.2%
0.01%
Q2 2019$2,000740.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders